JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2008;79:364-365; doi:10.1136/jnnp.2007.138081
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teasdale, T. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teasdale, T. W
Topic Collections
Right arrowRelevant Article

EDITORIAL COMMENTARIES

The apolipoprotein-{varepsilon}4 gene: always harmful?

Thomas W Teasdale

Correspondence to:
T W Teasdale, Department of Psychology, University of Copenhagen, Øster Farimagsgade 5, 1353 Copenhagen K, Denmark; tom.teasdale@psy.ku.dk

The first 150 words of the full text of this article appear below.

It has now long been established that the apolipoprotein epsilon 4 allele (APOE-isin4) on chromosome 19 constitutes a genetic risk factor for the development of Alzheimer’s disease.1 Since that discovery, APOE-isin4 has also often been implicated as being harmful in acquired types of brain injury including traumatic injury2 at least in the short term. Willemse-van Son et al’s evidence (see page 10.1136/jnnp.2007.129460) is reported to suggest, however, that APOE-isin4 can be associated with better, not worse, outcome following traumatic brain injury.3

What is distinctive in the design of their careful study is, first, that they followed traumatic brain injury patients up to 3 years post injury and, second, that they used a broad measure of outcome functioning. Their striking finding is that a group of patients carrying APOE-isin4 had, in the long term, a significantly better outcome, as measured by the Glasgow Outcome . . . [Full text of this article]


Relevant Article

Association between apolipoprotein-{varepsilon}4 and long-term outcome after traumatic brain injury
A H P Willemse-van Son, G M Ribbers, W C J Hop, C M van Duijn, and H J Stam
J. Neurol. Neurosurg. Psychiatry 2008 79: 426-430. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.